Per-oral Endoscopic Myotomy (POEM) in Patients With Postfundplication Dysphagia (VADYSMA)
A Prospective Pilot Trial of Per-oral Endoscopic Myotomy (POEM) in Patients With Postfundplication Dysphagia (VADYSMA Trial)
Laparoscopic fundoplication represents the standard antireflux procedure, when conservative measures fail. However, any type of fundoplication may be accompanied by adverse events. Postfundoplication dysphagia (PFD) may hamper results of anti-reflux surgery. Endoscopic pneumatic dilation has been considered as the first line treatment option for persistent PFD. However, studies have not confirmed its effectiveness in this indication. Peroral endoscopic myotomy (POEM) became a standard treatment for the management of esophageal achalasia and moreover has also been assessed in a small cohort of patients with refractory PFD and some patients achieved significant treatment success. The investigators plan to perform a prospective international cohort multicenter study assessing the efficacy of POEM in patients with persistent and severe PFD.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Jan Martínek, prof., MD
- Número de telefone: +420 723 708 839
- E-mail: jan.martinek@fnusa.cz
Estude backup de contato
- Nome: Martin Vašátko, MD
- Número de telefone: +420 739 476 451
- E-mail: martin.vasatko@fnusa.cz
Locais de estudo
-
-
-
Trnava, Eslováquia, 91701
- Ainda não está recrutando
- University Hospital Trnava
-
Contato:
- Rastislav Husťak, MD
- Número de telefone: +421 33/593 81 11
- E-mail: rhustak@gmail.com
-
Contato:
- Ján Ušák, MD
- Número de telefone: +421 33/593 81 11
- E-mail: jan.usak@gmail.com
-
-
Slovakia
-
Martin, Slovakia, Eslováquia, 03601
- Recrutamento
- Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava and University Hospital Martin,
-
Contato:
- Martin Duricek, Ass. Prof
- Número de telefone: +421 4203 973
- E-mail: martin.duricek@gmail.com
-
Contato:
- Peter Banovcin, Ass. Profesor
- Número de telefone: +421 4203 448
- E-mail: pbanovcin@gmail.com
-
-
-
-
-
Brno, Tcheca, 60200
- Recrutamento
- St. Anne's University Hospital Brno, Czech Republic
-
Contato:
- Jan Martínek, prof., MD
- Número de telefone: +420 723 708 839
- E-mail: jan.martinek@fnusa.cz
-
Contato:
- Martin Vašátko, MD
- Número de telefone: +420 739 476 451
- E-mail: martin.vasatko@fnusa.cz
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Patients after laparoscopic fundoplication procedure by Nissen (total, 360°), Dor (anterior, 180°) or Toupet (posterior, 270°) for gastroesophageal reflux disease no later than 10 years before enrolment.
- Refractory (> 6 months) and severe dysphagia after fundoplication procedure defined as an Eckardt score ≥3 and Mellow - Pinkas score ≥2 at baseline.
- X-ray (contrasted radiographic examination of the esophagus) characterized by both: a.) tapered narrowing of the distal esophagus and GEJ; b.) partial/total stagnation of the contrast solution above the GEJ
- Endoluminal planimetry: EGJ-DI < 3 mm2/mmHg (with 40ml)
- Age above 18 years
- Signed informed consent form
Exclusion Criteria:
- No previous attempt with at least one prokinetic drug
- Previous esophageal myotomy (open, laparoscopic or endoscopic)
- Primary esophageal motility disorder (achalasia etc.)
- Active erosive esophagitis
- Active peptic ulcer disease
- Esophageal stricture (peptic, malignant, other)
- Partial or complete supradiaphragmatic migration of the wrap and/or stomach (Hinder Type III - IV), Large hiatal hernia more than 5 cm
- Known eosinophilic esophagitis
- Severe coagulopathy
- Esophageal or gastric varices
- Advanced liver cirrhosis (Child B or Child C)
- Pregnancy or puerperium
- Malignant or pre-malignant esophageal diseases (dysplasia): patients with a history of such disease after its cure are eligible for enrolment
- Any other condition, which in the opinion of the investigator would interfere with study requirements
- Known gastroparesis
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: POEM arm
Patients, who will undergo peroral endoscopic myotomy for postfundoplication dysphagia |
All procedures will be performed by an experienced endoscopist, with a sufficient experience in "third space" endoscopy (at least 100 POEMs) under general anesthesia (internal preoperative examination is necessary) with a high-definition endoscope, fitted with a plastic distal attachment. Before the procedure, the patients will be administered intravenous antibiotics. Exclusively CO2 will be used for insufflation. POEM will be performed in a similar way as in patients with achalasia - the procedure consists of 4 steps: (1) mucosal incision and tunnel entry, (2) submucosal tunneling, (3) myotomy, and (4) closure of the mucosal entry with endoscopic clips or other closure devices. Perioperative protocol might differ according the usual way of performing POEM in a given center. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Efficacy POEM in patients with postfundoplication dysfagia
Prazo: 6 months
|
The primary outcome will be proportion of patients with treatment success defined as Eckardt score ≤ 2 and its decrease by at least 1 point after POEM at 6 months |
6 months
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Eckardt score
Prazo: At baseline, 3, 6 and 12 months
|
The Eckardt score is the grading system used for the evaluation of severity of symptoms in patients with esophageal achalasia. Four symptoms are assessed (dysphagia, regurgitation, chest pain and weight loss) and their severity ranges from 0 (no symptom) to 3 (with every meal). Total score is their sum and ranges from 0 to 12 |
At baseline, 3, 6 and 12 months
|
|
Mellow - Pinkas score
Prazo: At baseline, 3, 6 and 12 months
|
The Mellow - Pinkas score is used to assess dysphagia grade before and after the interventions. Total score ranges from 0 to 3 (0 = able to eat normal diet, 1 = able to swallow some solid foods, 2 = able to swallow only semi solid foods, 3 = able to swallow liquids only) |
At baseline, 3, 6 and 12 months
|
|
PAGI-QOL score (Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life)
Prazo: At baseline, 3, 6 and 12 months
|
The PAGI-QoL questionnaire contains of 30 items with five subscales: (1) daily activities; (2) clothing; (3) diet/food habits; (4) relationship; and (5) psychological well-being and distress. Each item is scored on a 6-point Likert scale, with response options ranging from 0 (none) to 5 (severe problem all of the time). Subscale scores are calculated by averaging the item responses. A total score is calculated by averaging subscale scores. Higher score means impairment in quality of life. |
At baseline, 3, 6 and 12 months
|
|
GERD-RHQL score (Gastroesophageal Reflux Disease Health-related Quality of Life)
Prazo: At baseline, 3, 6 and 12 months
|
The GERD-HRQL questionnaire was developed and validated to measure changes of typical GERD symptoms such as heartburn and regurgitation in response to surgical or medical treatment. Higher (greater) possible score means worst symptoms - ranging from 0 to 75. |
At baseline, 3, 6 and 12 months
|
|
Integrated Relaxation Pressure (IRP)
Prazo: At baseline, at 6 months
|
High resolution manometry - Median IRP recorded from 10 supine swallows, measured in mmHg. A value >15 mmHg indicates EGJ outflow obstruction. |
At baseline, at 6 months
|
|
Endoluminal planimetry (Endoflip)
Prazo: At baseline, ať 6 months
|
Pyloric distensibility measured by impedance planimetry (EndoFLIP device) |
At baseline, ať 6 months
|
|
Esophagogram
Prazo: At baseline, at 6 months
|
Esophagogram provides valuable information of the fundoplication, better appreciate a paraesophageal hernia and information on esophageal emptying. Patients will be advised overnight fasting prior to timed barium esophagogram. A contrast agent (e.g. barium, usually 100 to 250 mL) is ingested orally within 15-20 seconds. Left posterior oblique X-ray will be taken 2 and 5 minutes after contrast agent ingestion. Maximum esophageal width and column hights will be recorded at 2 and 5 minutes. |
At baseline, at 6 months
|
|
Eckardt score
Prazo: At baseline, 3 and 12 months
|
The Eckardt score is used to assess the severity of achalasia symptoms. It is based on the four main symptoms of achalasia: dysphagia, regurgitation, chest pain and weight loss. Each symptom has four levels of severity: none = 0 point, occasional = 1 point, daily = 2 points, each meal = 3 points. The sum of the points gives the final score. Final score scale: 0 (best) - 12 (worst). Treatment success is defined as a decrease of Eckardt score by at least 1 point and an overall Eckardt score ≤ 2. |
At baseline, 3 and 12 months
|
|
GERD
Prazo: At baseline, 3, 6 and 12 months
|
Presence of reflux esophagitis based on endoscopy findings. |
At baseline, 3, 6 and 12 months
|
|
Esophageal 24h-Hour pH metry
Prazo: At 3 months after procedure
|
An esophageal pH test measures how often stomach acid enters to the esophagus. It also measures how long the acid stays there. The test involves placing a catheter into the esophagus. The catheter or device will measure an acid level (known as pH level) for 24 hours. Post-POEM Esophageal acid exposure (DeMeester score, proportion of time with pH below 4)After |
At 3 months after procedure
|
|
PPI/H2 antagonists
Prazo: At baseline, 3, 6 and 12 months
|
PPI's and/or H2 antagonists use before and after procedure (POEM). |
At baseline, 3, 6 and 12 months
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- VADYSMA
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .